ALEXZA PHARMACEUTICALS INC.

Profile

Company Names

ALEXZA PHARMACEUTICALS INC.

Addresses

2091 STIERLIN COURT, MOUNTAIN VIEW, CA 94043

Phone Numbers

650.944.7000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$36,880,016.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2016-02-23 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
7
2015-09-28 
$143,750.00 
$143,750.00 
$0.00 
Equity 
6
2014-10-27 
$8,000,000.00 
$8,000,000.00 
$0.00 
Equity 
5
2014-03-18 
$3,457.00 
$3,457.00 
$0.00 
 
4
2012-03-15 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
3
2010-05-04 
$1,012,500.00 
$1,012,500.00 
$0.00 
 
2
2009-10-05 
$19,720,309.00 
$19,720,309.00 
$0.00 
Equity 
1
2009-08-26 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HAL 
V 
BARRON 
DIRECTOR
ALEXZA PHARMACEUTICALS INC.
J 
KEVIN 
BUCHI 
DIRECTOR
ALEXZA PHARMACEUTICALS INC.
ANDREW 
L 
BUSSER 
DIRECTOR
ALEXZA PHARMACEUTICALS INC.
JAMES 
V 
CASSELLA 
EXECUTIVE OFFICER
ALEXZA PHARMACEUTICALS INC.
SAMUEL 
D 
COLELLA 
DIRECTOR
ALEXZA PHARMACEUTICALS INC.
SAMUEL 
D. 
COLELLA 
DIRECTOR
JAZZ PHARMACEUTICALS INC   |  VERACYTE, INC.   |  FLUIDIGM CORP   |  VERSANT AFFILIATES FUND I-B LP   |  VERSANT AFFILIATES FUND I-A LP   |  VERSANT SIDE FUND I LP   |  ALEXZA PHARMACEUTICALS INC.   |  VERSANT SIDE FUND II, LP
ALAN 
D 
FRAZIER 
DIRECTOR
ALEXZA PHARMACEUTICALS INC.
EDWIN 
S 
KAMEMOTO 
EXECUTIVE OFFICER
ALEXZA PHARMACEUTICALS INC.
THOMAS 
B 
KING 
EXECUTIVE OFFICER, DIRECTOR
TAHOE RIDGE WINERY + MARKETPLACE LLC   |  ALEXZA PHARMACEUTICALS INC.   |  ZWEEMIE, LLC
ROBERT 
A 
LIPPE 
EXECUTIVE OFFICER
ALEXZA PHARMACEUTICALS INC.
ROBERT 
A. 
LIPPE 
EXECUTIVE OFFICER
ALEXZA PHARMACEUTICALS INC.
AUGUST 
J 
MORETTI 
EXECUTIVE OFFICER
ALEXZA PHARMACEUTICALS INC.
MARK 
K 
OKI 
EXECUTIVE OFFICER
ALEXZA PHARMACEUTICALS INC.
DEEPIKA 
R 
PAKIANATHAN 
DIRECTOR
ALEXZA PHARMACEUTICALS INC.
J 
LEIGHTON 
READ 
DIRECTOR
ALEXZA PHARMACEUTICALS INC.
GORDON 
 
RINGOLD 
DIRECTOR
ALAVITA PHARMACEUTICALS INC   |  ALEXZA PHARMACEUTICALS INC.   |  3-V BIOSCIENCES, INC.   |  MAVERIX BIOMICS, INC.   |  PROTEIN METRICS INC.   |  ARDELYX, INC.   |  SAGIMET BIOSCIENCES INC.   |  APEXIGEN, INC.   |  MAXYMUNE THERAPEUTICS, INC.
MICHAEL 
J 
SIMMS 
EXECUTIVE OFFICER
ALEXZA PHARMACEUTICALS INC.
ISAAC 
 
STEIN 
DIRECTOR
ALAVITA PHARMACEUTICALS INC   |  ALEXZA PHARMACEUTICALS INC.
JOSEPH 
L 
TURNER 
DIRECTOR
ALEXZA PHARMACEUTICALS INC.
JOSEPH 
L. 
TURNER 
DIRECTOR
CORCEPT THERAPEUTICS INC   |  ALEXZA PHARMACEUTICALS INC.   |  BIOCLIN THERAPEUTICS, INC.   |  MIRAGEN THERAPEUTICS, INC.   |  RAINIER THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-02-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-02-23 
2015-09-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-09-28 
2014-10-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-10-27 
2014-03-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2014-03-18 
2012-03-16
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-03-15 
2010-05-12
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2010-05-04 
2009-10-06
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2009-10-05 
2009-08-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2009-08-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
MORGAN STANLEY + CO. LLC
8209
MORGAN STANLEY + CO. LLC
8209
RBC CAPITAL MARKETS CORPORATION
31194
RBC CAPITAL MARKETS CORPORATION
31194